UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Microtubule Active Agents: Beyond the Taxane Frontier

Clinical cancer research, 2008-11, Vol.14 (22), p.7167-7172

2008

Link zum Volltext

Verfügbarkeit prüfen

The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment

The breast journal, 2012-01, Vol.18 (1), p.41-51

2012

Link zum Volltext

Verfügbarkeit prüfen

NCCN Task Force Report: Bone Health In Cancer Care

Journal of the National Comprehensive Cancer Network, 2013-08, Vol.11 Suppl 3, p.S1

2013

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer

Clinical cancer research, 2021-07, Vol.27 (14), p.3867-3875

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The lancet oncology, 2019-09, Vol.20 (9), p.1226-1238

2019

Link zum Volltext

Verfügbarkeit prüfen

Osteonecrosis of the Jaw Related to Bevacizumab

Journal of clinical oncology, 2008-08, Vol.26 (24), p.4037-4038

2008

Link zum Volltext

Verfügbarkeit prüfen

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.307-315

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Clinical breast cancer, 2018-10, Vol.18 (5), p.387-394

2018

Link zum Volltext

Verfügbarkeit prüfen

Approved Agents for Metastatic Breast Cancer

Seminars in oncology, 2011-06, Vol.38, p.S3-S10

Fornier, Monica N

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-term Clinical Outcomes of Whole-Breast Irradiation Delivered in the Prone Position

International journal of radiation oncology, biology, physics, 2007-05, Vol.68 (1), p.73-81

2007

Link zum Volltext

Verfügbarkeit prüfen

Denosumab: second chapter in controlling bone metastases or a new book?

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5127-5131

Fornier, Monica N

2010

Link zum Volltext

Verfügbarkeit prüfen

Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

Cancer, 2005-10, Vol.104 (8), p.1575-1579

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3399-3406

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy

Annals of translational medicine, 2020-12, Vol.8 (24), p.1694-1694

2020

Link zum Volltext

Verfügbarkeit prüfen

phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects

Journal of cancer research and clinical oncology, 2009-09, Vol.135 (9), p.1215-1221

2009

Link zum Volltext

Verfügbarkeit prüfen

NCCN Task Force Report: Bone Health in Cancer Care

Journal of the National Comprehensive Cancer Network, 2009-06, Vol.7 Suppl 3, p.S1

2009

Link zum Volltext

Verfügbarkeit prüfen

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2587-2595

2001

Link zum Volltext

Verfügbarkeit prüfen

Less Intense Dosing Schedule for a Bone-Modifying Agent

JAMA oncology, 2017-07, Vol.3 (7), p.893

Fornier, Monica N

2017

Link zum Volltext

Verfügbarkeit prüfen

Locoregional Outcomes of Inflammatory Breast Cancer Patients Treated With Standard Fractionation Radiation and Daily Skin Bolus in the Taxane Era

International journal of radiation oncology, biology, physics, 2010-07, Vol.77 (4), p.1105-1112

2010

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study

Journal of the American Geriatrics Society (JAGS), 2006-06, Vol.54 (6), p.925-931

2006

Link zum Volltext

Verfügbarkeit prüfen

Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer

Cancer prevention research (Philadelphia, Pa.), 2013-05, Vol.6 (5), p.428-436

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score

Journal of bone oncology, 2017-06, Vol.7 (C), p.32-37

2017

Link zum Volltext

Verfügbarkeit prüfen

Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer

Clinical breast cancer, 2014-12, Vol.14 (6), p.e111-e111

2014

Link zum Volltext

Verfügbarkeit prüfen

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

Supportive care in cancer, 2012-11, Vol.20 (11), p.2661-2668

2012

Link zum Volltext

Verfügbarkeit prüfen

Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases

Journal of oral and maxillofacial surgery, 2012-12, Vol.70 (12), p.2768-2775

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(108)

Sprache

Englisch
(107)
Japanisch
(10)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(77)
Science & Technology
(77)
Humans
(69)
Oncology
(69)
Female
(62)
Breast Neoplasms - Drug Therapy
(45)
Middle Aged
(33)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Aged
(31)
Breast Cancer
(31)
Adult
(29)
Breast Neoplasms - Pathology
(28)
Tumors
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Antineoplastic Agents - Therapeutic Use
(17)
Gynecology. Andrology. Obstetrics
(17)
Antineoplastic Agents
(16)
Chemotherapy
(16)
Mammary Gland Diseases
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microtubule Active Agents: Beyond the Taxane Frontier

The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment

NCCN Task Force Report: Bone Health In Cancer Care

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer

Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Osteonecrosis of the Jaw Related to Bevacizumab

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Approved Agents for Metastatic Breast Cancer

Long-term Clinical Outcomes of Whole-Breast Irradiation Delivered in the Prone Position

Denosumab: second chapter in controlling bone metastases or a new book?

Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy

phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects

NCCN Task Force Report: Bone Health in Cancer Care

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Less Intense Dosing Schedule for a Bone-Modifying Agent

Locoregional Outcomes of Inflammatory Breast Cancer Patients Treated With Standard Fractionation Radiation and Daily Skin Bolus in the Taxane Era

Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study

Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score

Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases

Suchergebnisse filtern